Otros
The latentiation process in drug design.
Fecha
1999-01-01Registro en:
Quimica Nova. Sao Paulo: Soc Brasileira Quimica, v. 22, n. 1, p. 75-84, 1999.
0100-4042
WOS:000078164200013
9734333607975413
0000-0003-4141-0455
Autor
Universidade Estadual Paulista (Unesp)
Universidade de São Paulo (USP)
Institución
Resumen
Short review about the main aspects of prodrug design, as its objectives, applicability and importance, showing the new trends in the research for selective latent forms, namely targeted drugs.